Diligence memo · auto-generated · as of July 2, 2026

royal wine medicine & food exhibition & marketing pte.ltd.

royal wine medicine & food exhibition & marketing pte.ltd. looks fair against its niche peers and is quiet on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

royal wine medicine & food exhibition & marketing pte.ltd. operates in Retailing, based in SINIGAPORE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

royal wine medicine & food exhibition & marketing pte.ltd. has raised $5.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $5.0M on 2024-12-09.

Most recent recorded round closed around 2024-12-09.

Valuation (modeled)modeled

Provath models royal wine medicine & food exhibition & marketing pte.ltd. at approximately $14M (range $6.1M–$27M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.77× the median modeled value of Series A Retailing companies in 2022–2024 (100 peers) — value vs value, same stage and era. Within the normal band (77% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 19 mo ago; this sector typically re-raises about every 13 months.

Slightly overdue versus sector cadence.

Comparablesmixed

Capital scale ranks ahead of 72% of Retailing peers (2347 compared).

Modeled value ranks above 70% of those peers.

Closest niche peers: Olivela Inc., PSP Investors, LLC, Coreleap, Inc., Cariloha, Inc., Elevation Cannabis, LLC.

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.